Page last updated: 2024-08-25

lycorine and Experimental Neoplasms

lycorine has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araki, M; Huang, P; Li, X; Liu, C; Matsuura, E; Nasu, Y; Sadahira, T; Sun, P; Wada, K; Wang, C; Watanabe, M; Xu, A; Xu, N; Xu, P; Xu, Y; Zheng, J	1

Other Studies

1 other study(ies) available for lycorine and Experimental Neoplasms

Article	Year
Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma. Oncotarget, 2017, Mar-28, Volume: 8, Issue:13 Topics: Amaryllidaceae Alkaloids; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; CTLA-4 Antigen; Drug Synergism; Female; Growth Inhibitors; Humans; Immunologic Factors; Immunotherapy; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phenanthridines; Plant Extracts; T-Lymphocyte Subsets; Treatment Outcome	2017

Article

Year

Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.

Oncotarget, 2017, Mar-28, Volume: 8, Issue:13

Topics: Amaryllidaceae Alkaloids; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; CTLA-4 Antigen; Drug Synergism; Female; Growth Inhibitors; Humans; Immunologic Factors; Immunotherapy; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phenanthridines; Plant Extracts; T-Lymphocyte Subsets; Treatment Outcome

2017